M
Manhattan Genomics develops precision gene correction therapies aimed at preventing inherited genetic diseases at the embryonic stage. The company focuses on addressing conditions like Cystic Fibrosis and Huntington’s Disease through in-vivo germline editing techniques. This work offers parents a proactive medical choice to eliminate the transmission of specific genetic disorders to future generations.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Manhattan Genomics develops precision gene correction therapies aimed at preventing inherited diseases at the embryonic stage. The company focuses on addressing the source of genetic conditions like Cystic Fibrosis and Huntington’s Disease before they manifest. This work is conducted under rigorous US regulatory oversight with a commitment to ethical transparency.